
what we do
Ovid was founded with the hope and determination to meaningfully improve the lives of people and families affected by neurological diseases. We strive to conquer epilepsies and brain conditions with courageous science. We are developing a next generation of targeted small molecule therapies that seek to reduce seizures and deliver improved safety and tolerability. Through compounds with unique or potential best-in-class mechanisms of action, we hope to pioneer effective new treatments, and one day, potentially change the course of disease.



